TY - JOUR T1 - FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 13N LP - 13N VL - 63 IS - 5 A2 - , Y1 - 2022/05/01 UR - http://jnm.snmjournals.org/content/63/5/13N.2.abstract N2 - ER -